Mr. Liver Implantation Method: An Innovative Conceptual Idea for the Proposed Liver Regenerative Strategy

Chronic viral hepatitis remains a major public health challenge and continues to contribute substantially to liver cirrhosis and hepatocellular carcinoma, particularly in Asia and in high-burden regions such as Hong Kong. Hepatitis A, B, C, and E differ in transmission route, clinical course, and long-term consequences, but hepatitis B and hepatitis C are especially important because of their association with chronic infection, progressive liver injury, cirrhosis, and malignant transformation. Over recent decades, vaccination, antiviral therapy, and biologic advances have improved prevention and disease control, yet hepatocellular carcinoma remains difficult to cure, and the prognosis of advanced disease is still poor [1][2]. This research paper reviews the epidemiology of hepatitis-related liver disease, the historical development of preventive and therapeutic measures, and current limitations in the treatment of liver cancer. It then proposes a speculative regenerative strategy termed the “Mr. Liver Implantation Method,” which is intended as a stem cell-based approach to hepatic repair and tissue replacement. The innovative concept is based on harvesting a small quantity of healthy liver tissue, expanding the cells under controlled culture conditions, and implanting the regenerated tissue into the patient to restore hepatic structure and function. This paper also introduces the idea of a bridging culture model using animal-derived organs, especially porcine liver, as a potential scaffold or intermediate platform for tissue expansion. Although the proposed approach is highly theoretical, it is framed within the broader context of regenerative medicine, tissue engineering, and organ restoration. The discussion emphasizes the liver’s intrinsic regenerative capacity and the potential of patient-derived cells to reduce immunologic incompatibility.